M. Neufeld et al., High-density lipoproteins inhibit fibrinogen binding on adenosine diphosphate-activated monocytes, BL COAG FIB, 11(6), 2000, pp. 505-509
High levels of fibrinogen and tow levels of high-density lipoprotein (HDL)
cholesterol were reported to be risk factors for coronary heart disease. CD
11b/CD18, a fibrinogen-binding protein, is expressed on the surface of mono
cytes, which play a crucial role in the formation of atherosclerotic lesion
s. In the present study, we investigate the effects of antibodies against C
D11b and CD18, as well as HDL3 and low-density lipoprotein (LDL) cholestero
l on fibrinogen binding on monocytes. We find that binding of fibrinogen on
monocytes activated with adenosine diphosphate (ADP) was reduced to 66.0 /- 8.3% (mean ie SD) in the presence of anti-CD11b antibodies (12.5 mu g/ml
; P less than or equal to 0.02) and to 54.5 4.9% in the presence of anti-CD
18 antibodies (20 mu g/ml; P less than or equal to 0.01), respectively. Fib
rinogen binding on Cytochalasin-B-activated monocytes was reduced to 79.8 /- 6.0% in the presence of anti-CD18 (20 mu g/ml; P less than or equal to 0
.05). Incubation of ADP-activated monocytes with HDL3 (0.5 g/l) led to a lo
wering of fibrinogen binding to 65.0 +/- 6.6% (P less than or equal to 0.05
). No effect of HDL3 on fibrinogen binding was seen on Cytochalasin-B-activ
ated monocytes. A slight, non-significant stimulatory effect of LDL on fibr
inogen binding on ADP-activated but not on Cytochalasin-B-activated monocyt
es was additionally observed. Neither incubation with HDL3 or with LDL had
a significant influence on ADP-activated cellular binding of anti-CD11b or
anti-CD18 antibodies. The inhibition of fibrinogen binding on monocytes in
the presence of HDL3 is a major new finding of this study. Since inhibition
of fibrinogen binding in the presence of HDL might impair both monocyte re
cruitment to the arterial wall and foam cells formation, our findings sugge
sts a novel mechanism by which HDL may prevent development of arteriosclero
sis. Blood Coagul Fibrinolysis 11:505-509 (C) 2000 Lippincott Williams & Wi
lkins.